Jeanette E Eckel-Passow

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi Normalization of two-channel microarray experiments: a semiparametric approach
    J E Eckel
    Department of Health Sciences Research, Mayo Clinic Rochester, MN 55905, USA
    Bioinformatics 21:1078-83. 2005
  2. ncbi Experimental design and analysis of antibody microarrays: applying methods from cDNA arrays
    Jeanette E Eckel-Passow
    Department of Health Sciences Research, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA
    Cancer Res 65:2985-9. 2005
  3. ncbi Regression analysis for comparing protein samples with 16O/18O stable-isotope labeled mass spectrometry
    J E Eckel-Passow
    Division of Biostatistics, Department of Health Sciences Research 200 First Street SW, Rochester, MN 55905, USA
    Bioinformatics 22:2739-45. 2006
  4. ncbi Software comparison for evaluating genomic copy number variation for Affymetrix 6.0 SNP array platform
    Jeanette E Eckel-Passow
    Division of Biomedical Statistics and Informatics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    BMC Bioinformatics 12:220. 2011
  5. ncbi A method for automatically interpreting mass spectra of 18O-labeled isotopic clusters
    Christopher J Mason
    Mayo Proteomics Research Center, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Mol Cell Proteomics 6:305-18. 2007
  6. ncbi Integrated analysis of gene expression, CpG island methylation, and gene copy number in breast cancer cells by deep sequencing
    Zhifu Sun
    Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America
    PLoS ONE 6:e17490. 2011
  7. ncbi Incidence of Pseudomonas aeruginosa bacteremia: a population-based study
    Majdi N Al-Hasan
    Department of Medicine, Division of Infectious Diseases, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Am J Med 121:702-8. 2008
  8. ncbi An insight into high-resolution mass-spectrometry data
    J E Eckel-Passow
    Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    Biostatistics 10:481-500. 2009
  9. ncbi Expression of endothelin 2 and localized clear cell renal cell carcinoma
    Brian M Bot
    Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN 55905, USA
    Hum Pathol 43:843-9. 2012
  10. ncbi Statistical analysis of relative labeled mass spectrometry data from complex samples using ANOVA
    Ann L Oberg
    Division of Biostatistics, Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA
    J Proteome Res 7:225-33. 2008

Collaborators

Detail Information

Publications15

  1. ncbi Normalization of two-channel microarray experiments: a semiparametric approach
    J E Eckel
    Department of Health Sciences Research, Mayo Clinic Rochester, MN 55905, USA
    Bioinformatics 21:1078-83. 2005
    ..The proposed normalization procedure is applied to a two-channel dose-response experiment...
  2. ncbi Experimental design and analysis of antibody microarrays: applying methods from cDNA arrays
    Jeanette E Eckel-Passow
    Department of Health Sciences Research, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA
    Cancer Res 65:2985-9. 2005
    ..The objective of this article is to discuss statistical methods that have been developed for cDNA arrays and describe how the methods can be directly applied to antibody arrays...
  3. ncbi Regression analysis for comparing protein samples with 16O/18O stable-isotope labeled mass spectrometry
    J E Eckel-Passow
    Division of Biostatistics, Department of Health Sciences Research 200 First Street SW, Rochester, MN 55905, USA
    Bioinformatics 22:2739-45. 2006
    ..Although discussed in the context of (16)O/(18)O stable-isotope labeled data, the multivariable regression models are generalizable to other stable-isotope labeled technologies...
  4. ncbi Software comparison for evaluating genomic copy number variation for Affymetrix 6.0 SNP array platform
    Jeanette E Eckel-Passow
    Division of Biomedical Statistics and Informatics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    BMC Bioinformatics 12:220. 2011
    ..0. We compared bias and variance in the locus-level copy number data, the concordance amongst regions of copy number gains/deletions and the false-positive rate amongst deleted segments...
  5. ncbi A method for automatically interpreting mass spectra of 18O-labeled isotopic clusters
    Christopher J Mason
    Mayo Proteomics Research Center, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Mol Cell Proteomics 6:305-18. 2007
    ..We describe in detail the operation of the algorithm and demonstrate its use on datasets with known and unknown ratios...
  6. ncbi Integrated analysis of gene expression, CpG island methylation, and gene copy number in breast cancer cells by deep sequencing
    Zhifu Sun
    Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, United States of America
    PLoS ONE 6:e17490. 2011
    ..The role of gene amplification/deletion appears to more modest, although several potentially significant genes appear to be regulated by copy number aberrations...
  7. ncbi Incidence of Pseudomonas aeruginosa bacteremia: a population-based study
    Majdi N Al-Hasan
    Department of Medicine, Division of Infectious Diseases, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Am J Med 121:702-8. 2008
    ..The incidence of Pseudomonas aeruginosa bacteremia has not been defined in a population-based investigation...
  8. ncbi An insight into high-resolution mass-spectrometry data
    J E Eckel-Passow
    Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    Biostatistics 10:481-500. 2009
    ..Areas in need of statistical research for proteomic data include alignment, experimental design, abundance normalization, and statistical analysis...
  9. ncbi Expression of endothelin 2 and localized clear cell renal cell carcinoma
    Brian M Bot
    Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN 55905, USA
    Hum Pathol 43:843-9. 2012
    ..If supportive mechanistic data can be produced, endothelin 2 could represent a potential target for chemopreventive or neoadjuvant therapeutics for clear cell renal cell carcinoma...
  10. ncbi Statistical analysis of relative labeled mass spectrometry data from complex samples using ANOVA
    Ann L Oberg
    Division of Biostatistics, Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA
    J Proteome Res 7:225-33. 2008
    ..The modeling approach, implementation, and useful visualization tools are demonstrated via a case study of complex biological samples assessed using the iTRAQ relative labeling protocol...
  11. ncbi Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL® platform
    Monica M Reinholz
    Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First St SW, Rochester, Minnesota 55905, USA
    BMC Med Genomics 3:60. 2010
    ..5K) and 24,526-gene panel (24K) platforms at differentiating nine human epidermal growth factor receptor 2- positive (HER2+) and 11 HER2-negative (HER2-) paraffin-embedded breast tumors...
  12. ncbi A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection
    Albert J Eid
    Divisions of Infectious Diseases, Department of Medicine, College of Medicine, Mayo Clinic, Rochester, MN, USA
    Transpl Int 23:506-13. 2010
    ..On the other hand, the clinical utility of CMV-specific T cell assays will need to be assessed in a larger cohort of CMV D+/R- kidney recipients who remain at high-risk of delayed-onset CMV disease...
  13. ncbi Tissue microarrays: one size does not fit all
    Jeanette E Eckel-Passow
    Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Diagn Pathol 5:48. 2010
    ..Furthermore, TMA performance across multiple biomarkers has not been systematically explored...
  14. ncbi Progressive but previously untreated CLL patients with greater array CGH complexity exhibit a less durable response to chemoimmunotherapy
    Neil E Kay
    Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Cancer Genet Cytogenet 203:161-8. 2010
    ..1 deletion and in the more favorable genetic subtype characterized by the presence of 13q14.1 deletion. This aCGH study adds information on the association between poor trial response and increasing genetic complexity as CLL progresses...
  15. ncbi Kinetics of interferon-gamma producing cytomegalovirus (CMV)-specific CD4+ and CD8+ T lymphocytes and the risk of subsequent CMV viremia after allogeneic hematopoietic stem cell transplantation
    A J Eid
    Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Transpl Infect Dis 11:519-28. 2009
    ..Deficiencies in cytomegalovirus (CMV)-specific T lymphocytes impair the immunologic response against CMV reactivation after allogeneic hematopoietic stem cell transplantation (HSCT)...